What motivates you?

The opportunity to meet and support passionate teams and innovative businesses working on transforming healthcare, be it improving access to care or pioneering new treatments. Witnessing the investment journey end to end and working alongside entrepreneurs from ideation to execution fills me with a deep sense of purpose.

What’s been the steepest learning curve on your career journey so far?

My first stint with the fund was just a few months before the COVID-19 pandemic brought the world to a standstill. As I adapted to a new team and role, I realized how crucial it was to help companies navigate both operational and market challenges. Collaborating closely with founders taught me the importance of adaptability and resilience, as each investment presented unique obstacles, from regulatory shifts to the urgent need for innovative solutions. This experience has been invaluable in refining my approach to investing in impactful healthcare innovations

Which global healthcare trend are you most excited about at the moment and why?

Longevity science is an upcoming trend that's most exciting. Advances in biotechnology and genomics are deepening our understanding of aging and driving innovations to extend healthy lifespans. This area has immense potential to improve quality of life while addressing societal challenges posed by aging populations. Though nascent, the expanding market for longevity-related products and services will present significant investment opportunities, particularly in regenerative medicine and age-related therapeutics

What’s the best piece of advice you’ve ever received?

Prioritizing relationship building over simply chasing opportunities. Investing is about the people behind the ideas, and once you make an investment, you need to work closely with those individuals. Taking the time to connect with founders and their teams has helped me make better decisions and foster more successful partnerships.